Swedish Dementia Registry (SveDem) (Sweden) **
Karin Westling
National coordinator, SveDem
SWEDEN
Phone: +468123 897 83
Mobile phone: +46700 85 66 78
Email: svedem.karolinska@regionstockholm.se
Dorota Religa
Chair, SveDem
SWEDEN
Email: svedem.karolinska@regionstockholm.se
1: Mo M, Abzhandadze T, Hoang MT, Sacuiu S, Jurado PG, Pereira JB, Naia L, Kele J, Maioli S, Xu H, Eriksdotter M, Garcia-Ptacek S. Antidepressant use and cognitive decline in patients with dementia: a national cohort study. BMC Med. 2025 Feb 25;23(1):82.
2: Abzhandadze T, Hoang MT, Raaschou P, Norgren J, Mo M, Molnar C, Xu H, Kananen L, Åkerman M, Religa D, Eriksdotter M, Garcia-Ptacek S. Temporal trends in sex differences in dementia care-results from the Swedish registry for cognitive/dementia disorders, SveDem. Sci Rep. 2025 May 29;15(1):18890.
3: Petek B, Mo M, Xu H, Norgren J, Hoang MT, Villa-Lopez M, Häbel H, Kele J, Naia L, Maioli S, Pereira JB, Gregorič Kramberger M, Winblad B, Eriksdotter M, Carrero JJ, Garcia-Ptacek S. Statins, cholesterol and cognition at the time of Alzheimer's disease diagnosis: A cross-sectional study from the Swedish registry for cognitive/dementia disorders. J Alzheimers Dis Rep. 2025 Oct 3;9:25424823251385903.
4: Kårelind F, Johansson L, Zarit S, Wijk H, Bielsten T, Finkel D. Factors influencing time to support in young-onset dementia: survival analysis of data from the Swedish Dementia Registry (SveDem). Aging Ment Health. 2025 Jun;29(6):992-999.
5: Skillbäck TB, Jönsson L, Skoog I, Blennow K, Eriksdotter M, Zetterberg H, Kern S. Cerebrospinal Fluid Biomarkers for Alzheimer Disease Among Patients With Dementia. JAMA Neurol. 2025 Jun 1;82(6):580-588.
6: Grau-Jurado P, Mostafaei S, Xu H, Mo M, Petek B, Kalar I, Naia L, Kele J, Maioli S, Pereira JB, Eriksdotter M, Chatterjee S, Garcia-Ptacek S. Medications and cognitive decline in Alzheimer's disease: Cohort cluster analysis of 15,428 patients. J Alzheimers Dis. 2025 Feb;103(3):931-940.
7: Aye S, Frisell O, Zetterberg H, Skillbäck TB, Kern S, Eriksdotter M, Aho E, Xia X, Winblad B, Wimo A, Jönsson L. Costs of Care in Relation to Alzheimer's Disease Severity in Sweden: A National Registry-Based Cohort Study. Pharmacoeconomics. 2025 Feb;43(2):153-169.
8. External Causes of Death From Death Certificates in Patients With Dementia. Mo M, Xu H, Hoang MT, Jurado PG, Mostafaei S, Kåreholt I, Johnell K, Eriksdotter M, Garcia-Ptacek S. J Am Med Dir Assoc. 2023 Sep;24(9):1381-1388.
9. Hoang MT, Jurado PG, Abzhandadze T, Mostafaei S, Mo M, Åkerman M, Vestling K, Chen C, Xu H, Eriksdotter M, Garcia-Ptacek S. Effects of the COVID-19 Pandemic on the Number of New Dementia Diagnoses and the Quality of Dementia Diagnostics and Treatment. J Prev Alzheimers Dis. 2024;11(6):1703-1711.
10. Shahim B, Xu H, Haugaa K, Zetterberg H, Jurga J, Religa D, Eriksdotter M. Cholinesterase inhibitors are associated with reduced mortality in patients with Alzheimer's disease and previous myocardial infarction. Eur Heart J Cardiovasc Pharmacother. 2024 Feb 23;10(2):128-136.